knowledge -WSS

knowledge

author：leisure time 2025-09-30 17:44:04 - browse：6

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Bernie brings in new pharma CEOs to talk drug prices

focus

WSS

Venture capitalist Bob Kocher on the state of digital health

What’s missing from the debate over nursing home staff minimums

Criminal prosecution for violating HIPAA: an emerging threat

Bird flu: Don't repeat Covid's 'health versus the economy' framing

A single Democrat is willing to weaken Medicare negotiation power

AstraZeneca stays mum on Medicare drug pricing negotiations

hotspot

knowledge

focus

Sports medicine is finally prioritizing gender equality

Wearables generate powerful data but its not useful to doctors, yet

Psychedelics group wrestles with new pharma identity

Readers respond to H5N1 and livestock movements, and more

Medical leaders decry Supreme Court decision on affirmative action

Solving academic medical centers' existential crisis

Medical leaders decry Supreme Court decision on affirmative action

When prostate cancer spreads, where it goes matters

Supreme Court strikes down use of affirmative action

Readout Newsletter: Amgen, Regeneron, BGI Group and more

hotspot

Devoted Health’s losses in Medicare Advantage persist

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Readers respond to H5N1 and livestock movements, and more

NVIDIA and Google execs on the future of AI and drug discovery

Adopting new red light myopia treatments may be short

Cano Health’s bankruptcy is a warning for Medicare Advantage

knowledge

hotspot

focus

leisure time